Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Advertisement
GAM ID: header
Letter to the Editor
Page 71
Posts about this type
JCP
Letter to the Editor
Clozapine in the Treatment of Aggression in an Adolescent With Autistic Disorder
June 1, 2001
Neal C. Chen
,
Hany S. Bedair
,
Bernice McKay
, et al
JCP
Letter to the Editor
Clozapine in the Treatment of Hypomania With Neurosyphilis
June 1, 2001
Rathi Mahendran
JCP
Letter to the Editor
Gabapentin for the Treatment of Patients With Somatization Disorder
June 1, 2001
Javier Garcia-Campayo
,
Concepcion Sanz-Carrillo
JCP
Letter to the Editor
Internet-Observed Suicide Attempts
June 1, 2001
Marc P. Janson
,
Edward S. Alessandrini
,
Sasha S. Strunjas
, et al
JCP
Letter to the Editor
Seizure During Combination of Trimipramine and Bupropion
June 1, 2001
Murray W. Enns
JCP
Letter to the Editor
Topiramate Abuse in a Bipolar Patient With an Eating Disorder
June 1, 2001
Francesc Colom
,
Eduard Vieta
,
Antonio Benabarre
, et al
PCC
Letter to the Editor
Dysphagia and Chronic Mental Illness: Looking Beyond Hysteria and Broadening the Psychiatric Differential Diagnosis
June 1, 2001
Jeffrey G. Stovall
,
Lisa S. Gussak
PCC
Letter to the Editor
Mirtazapine-Associated Withdrawal Symptoms: A Case Report
June 1, 2001
Timothy R. Berigan
JCP
Letter to the Editor
Increase in Plasma Levels of Clozapine and Norclozapine After Administration of Nefazodone
May 1, 2001
Ahsan Y. Khan
,
Sheldon H. Preskorn
JCP
Letter to the Editor
Mirtazapine-Associated Palinopsia
May 1, 2001
Thomas Ihde-Scholl
,
James W. Jefferson
JCP
Letter to the Editor
Reply to Letter to the Editor "Type II Error and Antidepressants"
May 1, 2001
Karen L. Weihs
,
Sharyn R. Batey
,
Trisha L. Houser
, et al
JCP
Letter to the Editor
Type II Error and Antidepressants
May 1, 2001
J. Bryan Walker
,
Robert M. Klein
,
Sook-Ling Yee
JCP
Letter to the Editor
Cost Savings With Intramuscular Anticholinergics
April 1, 2001
John S. Markowitz
,
Stephen McLeod-Bryant
,
Cherry Wyant Jackson
JCP
Letter to the Editor
Low-Dose Olanzapine for Self-Mutilation Behavior in Patients With Borderline Personality Disorder
April 1, 2001
David W. Hough
JCP
Letter to the Editor
Olanzapine in the Treatment of Tardive Dyskinesia: A Report of 2 Cases
April 1, 2001
Vivek Agarwal
,
Parvesh Kumar
JCP
Letter to the Editor
Problems With Ensuring a Double Blind
April 1, 2001
Shailesh Kumar
,
Mark Oakley-Browne
JCP
Letter to the Editor
Reply to Letter to the Editor "Problems With Ensuring a Double Blind"
April 1, 2001
Raffaella Zanardi
,
David Rossini
,
Alessandro Serretti
JCP
Letter to the Editor
Successful Treatment of Nondelusional Body Dysmorphic Disorder With Olanzapine: A Case Report
April 1, 2001
Jon E. Grant
PCC
Letter to the Editor
Psychiatric Uses of Newer Anticonvulsants
April 1, 2001
Timothy R. Berigan
JCP
Letter to the Editor
Emergence of PTSD in Trauma Survivors With Dementia
March 1, 2001
Margriet E. van Achterberg
,
Robert M. Rohrbaugh
,
Steven M. Southwick
JCP
Letter to the Editor
Fatal Body Dysmorphic Disorder by Proxy
March 1, 2001
Naureen Atiullah
,
Katharine A. Phillips
JCP
Letter to the Editor
Lithium Intoxication After Administration of AT¹ Blockers
March 1, 2001
Peter Zwanzger
,
Alain Marcuse
,
Reinhard J. Boerner
, et al
JCP
Letter to the Editor
Physical Restraints, Thromboembolism, and Death in 2 Patients
March 1, 2001
Arthur Lazarus
JCP
Letter to the Editor
Treatment of Refractory Major Depression With Tramadol Monotherapy
March 1, 2001
Nathan Andrew Shapira
,
Marcia L. Verduin
,
John D. DeGraw
«
1
…
69
70
71
72
73
…
86
»
